Imperial healthcare technologies of the future boosted by new DTI fundNovember 20, 2002Two new technologies with the potential to transform healthcare have won scientists at Imperial College London almost a third of a new UKP 8 million research programme funded by the Department of Trade and Industry (DTI), it is announced today. The Beacon research programme, part of a DTI initiative to provide a platform for UK world-class research in the areas of bioinformatics, bio-imaging and nanotechnology, will focus on developing technologies that will provide novel healthcare solutions. Paul French, Professor of Physics, will lead a team with members from every faculty of Imperial to develop fluorescence lifetime imaging technology. "Fluorescence lifetime imaging provides an enormous opportunity to reveal mechanisms underlying the fundamental biology of disease and to provide new clinical diagnostic tools. This has become possible because of advances in ultrafast laser and imaging technology," said Professor French. "Our Beacon award provides a unique opportunity to develop an integrated interdisciplinary approach to develop immensely exciting instrumentation for molecular biology, medicine and drug discovery." The project will also provide a novel way of investigating the trafficking and communication between proteins in the body. Imperial's second award winner, Stephen Muggleton, Professor of Bioinformatics in the Department of Computing will lead a team in developing computer technology to fine-tune therapeutic drug design. Using expertise from biological science, medicine and computing the team will develop an industrial-strength computing tool that will allow the modelling of disease pathways and predict the toxicity of potential drugs. This tool will assist in the search for effective drugs and reduce the expense in their development. "Research and development in the pharmaceutical industry involves laboratories of chemists synthesising and testing hundreds of compounds often at great expense. It is now possible to construct 'rules' that predict whether drugs will work from examples of drugs with known medicinal activity," said Professor Muggleton. "During the 21st century, it is already clear that computers will play an increasingly central role in supporting the fundamental formulation and testing of scientific hypotheses," he added. Both Imperial projects will harness the strong interdisciplinary and entrepreneurial culture at Imperial to help develop new drugs and deliver improved detection and treatment of disease. Imperial scientists will join representatives from the four other Beacon projects and Science and Innovation Minister, Lord Sainsbury, in celebrating the research programme launch at the Globe Theatre, London on 20 November 2002. -ends- | |||||||||||||||||||||
|
Related Aging Current Events and Aging News Articles Primary care provides patients with better outcomes at lower cost A white paper, How is a Shortage of Primary Care Physicians Affecting the Quality and Cost of Medical Care?, released today by the American College of Physicians (ACP) documents the value of primary care by reviewing 20 years of research. Study Investigates Non-Surgical Placement of a Gore-tex Type Device in the Heart to Stop Recurrent Strokes and Mini-Strokes A study is under way at Rush University Medical Center using a small, soft-patch device made of a Gore-tex-type material - often used to make durable outerwear - to close a common hole found in the heart called a patent foramen ovale (PFO) in order to prevent recurrent strokes and transient ischemic attacks (TIAs) in adults. Scientists Discover New Planet Orbiting Dangerously Close to Giant Star A team of astronomers from Penn State and Nicolaus Copernicus University in Poland has discovered a new planet that is closely orbiting a red-giant star, HD 102272, which is much older than our own Sun. Exercise increases brain growth factor and receptors, prevents stem cell drop in middle age A new study confirms that exercise can reverse the age-related decline in the production of neural stem cells in the hippocampus of the mouse brain, and suggests that this happens because exercise restores a brain chemical which promotes the production and maturation of new stem cells. Super-Tough Sunshield to Fly on the James Webb Space Telescope Imagine sunglasses that can withstand the severe cold and heat of space, a barrage of radiation and high-speed impacts from small space debris. They don't exist, but Northrop Grumman engineers have created a Sunshield for NASA's James Webb Space Telescope that can withstand all of those elements. The space telescope needs a Sunshield to block heat from the sun so its cameras and instruments can operate properly a million miles from the Earth, when it launches in 2013. SNPs affect folate metabolism in study of Puerto-Rican adults Researchers at Tufts University have gained further understanding of the genomic basis for altered folate metabolism and the content of uracil in blood DNA. Caring for the caregiver: Redefining the definition of patient One quarter of all family caregivers of Alzheimer's disease patients succumb to the stress of providing care to a loved one and become hospital patients themselves, according to an Indiana University study published in the November 2008 issue of the Journal of General Internal Medicine. Researchers use chemical from medicinal plants to fight HIV Like other kinds of cells, immune cells lose the ability to divide as they age because a part of their chromosomes known as a telomere becomes progressively shorter with cell division. As a result, the cell changes in many ways, and its disease fighting ability is compromised. New study shows that important gene controls the ability of the thymus to produce disease-fighting T-cells after an organism's birth New research, just published by researchers from the University of Georgia, provides the first evidence that a key gene may be crucial to maintaining the production of the thymus and its disease-fighting T-cells after an animal's birth. An Anti-Frailty Pill for Seniors? Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty. More Aging Current Events and Aging News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||